je.st
news
Tag: monsantos
Help fund the Roundup class action lawsuit to stop Monsanto's false labeling of this deadly poison
2015-06-22 02:00:39| Chemicals - Topix.net
Three residents of Los Angeles have filed a class action lawsuit against the Monsanto Company for false and misleading advertising. Monsanto's Roundup herbicide currently bears the claim "Glyphosate targets an enzyme found in plants but not in people or pets " that is patently false, and plaintiffs are seeking both monetary damages and a preliminary and permanent injunction against Monsanto's continued use of this false claim.
Monsanto's latest bid could test its lobbying might
2015-06-12 20:19:39| Chemicals - Topix.net
The bid by the world's largest seller of crop seeds, Monsanto , to take over the world's largest seller of pesticides, Swiss giant Syngenta AG , may never come to fruition. At the moment, Sygenta is rejecting the overture, arguing that the $45 billion offer is inadequate - and worrying about the reputational risk of merging with a company that's perceived as carrying some undesirable baggage.
Syngenta rejects Monsantos $2bn reverse break-up fee proposal
2015-06-09 01:00:00| Food Processing Technology
Syngenta has rejected a second takeover proposal from US sustainable agriculture company Monsanto, despite offers to pay a $2bn reverse break-up fee if the company cannot obtain global regulatory approvals.
Tags: fee
reverse
proposal
rejects
Monsanto's sick new power play: Why we could all be eating their GMOs
2015-05-31 12:14:09| Chemicals - Topix.net
Earlier this month, Swiss seed and agrochemical company Syngenta rejected Monsanto's second takeover bid in a year. Syngenta's board said the offer undervalued the company and did not fully address regulatory risks.
Monsanto's sick new power play: Why we could all be eating their GMOs
2015-05-31 11:23:27| Biotech - Topix.net
Earlier this month, Swiss seed and agrochemical company Syngenta rejected Monsanto's second takeover bid in a year. Syngenta's board said the offer undervalued the company and did not fully address regulatory risks.